Empagliflozin 25mg
Empagliflozin 25mg is primarily prescribed for managing type 2 diabetes mellitus. Acting as an inhibitor of sodium-glucose cotransporter-2 (SGLT2), it aids in lowering blood sugar levels by facilitating the removal of glucose from the bloodstream through urine. Additionally, it may contribute to reducing the risk of cardiovascular events in diabetic patients.
Uses:
Empagliflozin 25mg is primarily prescribed for managing type 2 diabetes mellitus. Acting as an inhibitor of sodium-glucose cotransporter-2 (SGLT2), it aids in lowering blood sugar levels by facilitating the removal of glucose from the bloodstream through urine. Additionally, it may contribute to reducing the risk of cardiovascular events in diabetic patients.
Dosage:
Typically, Empagliflozin 25mg is taken orally once daily, with or without food. Dosage adjustments may be necessary depending on individual response and kidney function. It’s crucial to strictly adhere to the prescribed dosage as directed by a healthcare provider.
Manufacturer:
Empagliflozin 25mg is crafted by several pharmaceutical companies globally, including Boehringer Ingelheim and Eli Lilly and Company. These manufacturers uphold rigorous quality standards to ensure the safety and efficacy of the medication.
How to Use:
Administration of Empagliflozin 25mg involves oral intake with a glass of water, usually in the morning. Patients should follow the instructions provided by their healthcare provider or pharmacist. It’s important to swallow the tablets whole without crushing or chewing.
Side Effects:
Common side effects of Empagliflozin 25mg may include urinary tract infections, genital yeast infections, increased urination, dehydration, and low blood pressure. Less common side effects such as ketoacidosis and kidney problems may also occur. Patients should promptly report any unusual symptoms to their healthcare provider.
Precautions and Warnings:
Before initiating Empagliflozin 25mg, patients should inform their healthcare provider about any allergies, medical conditions, or medications they are taking. Regular monitoring of blood sugar levels is essential, and medical attention should be sought if symptoms of ketoacidosis or dehydration arise.
Drug Interactions:
Empagliflozin 25mg may interact with certain medications, including diuretics, insulin, and other antidiabetic drugs. Patients should disclose all medications they are taking to their healthcare provider to avoid potential interactions.
Overdose Information:
In the event of an overdose, patients should seek immediate medical attention or contact a poison control center. Symptoms of overdose may include increased urination, dehydration, and low blood pressure.
Pregnancy and Lactation:
The safety of Empagliflozin 25mg during pregnancy and lactation has not been established. Pregnant or breastfeeding individuals should consult their healthcare provider before using this medication.
Quantity | 120, 180, 240, 60 |
---|---|
Manufacturer | Boehringer |
Indian Brand | Jardiance 25mg |
US Brand Name | Empagliflozin, Jardiance |
Generic Name | Empagliflozin 25mg |
Dosage | 25mg |
Drug Type | Tablets |
Reviews
There are no reviews yet.